Scientists have identified a new treatment combination that is highly effective at suppressing the growth of head and neck tumours.
List view / Grid view
The Mark Foundation for Cancer Research awards ~$12 million to Cancer Grand Challenges Team to develop new immunotherapies for childhood solid tumours.
Researchers have developed a ground-breaking microscopy technique that allows proteins, DNA, and other tiny biological particles to be studied in their natural state in a completely new way.
A new study has highlighted two broadly neutralising antibodies show great promise to provide long-acting immunity against COVID-19 in immunocompromised populations.
Scientists have identified an important new mechanism that causes the heart’s muscle to thicken which markedly increases the risk of irregular heart rhythms and cardiac hypertrophy.
Researchers have developed a new technology that could offer treatment for HIV infection through a single injection.
The study found female mice currently receiving testosterone had fewer and less developed eggs retrieved. In contrast, discontinuing testosterone therapy in mice led to similar egg retrieval rates compared to the control group.
A new study in mice has shown blood cancer treatment with protein interleukin-7 revs up T-cell immunotherapy.
Scientists have demonstrated how killer T cells used in immunotherapy to eliminate cancer cells can also destroy tumour lymphatic vessels, thus greatly reducing the risk of metastasis.
A new study has revealed how some fast-growing bacteria could be retreated with antibiotics.
A new study has highlighted that the interferon gamma receptor pathway is necessary for CAR T-cell mediated killing in solid tumours.
Targeting these brain circuits could offer a new way to reverse motor dysfunction and depression in Parkinson’s disease patients.
The new study highlights 11 genes which could be considered as potential candidates for novel therapeutics for type 1 diabetes.
New research has found that microbial fermentation of dietary fibre in the gut can protect against allergic skin diseases.
Scientists have found that an immune protein, CSF1, may cause anxiety during alcohol withdrawal, therefore causing relapse.